<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>13</volume><submitter>Fang C</submitter><funding>Natural Science Foundation of Hunan Province</funding><funding>National Natural Science Foundation of China</funding><pubmed_abstract>&lt;b>Background:&lt;/b> Dexmedetomidine is a commonly used clinical sedative; however, the drug response varies among individuals. Thus, the purpose of this study was to explore the association between dexmedetomidine response and gene polymorphisms related to drug-metabolizing enzymes and drug response (&lt;i>CYP2A6&lt;/i>, &lt;i>UGT2B10&lt;/i>, &lt;i>UGT1A4&lt;/i>, &lt;i>ADRA2A&lt;/i>, &lt;i>ADRA2B&lt;/i>, &lt;i>ADRA2C&lt;/i>, &lt;i>GABRA1&lt;/i>, &lt;i>GABRB2&lt;/i>, and &lt;i>GLRA1&lt;/i>). &lt;b>Methods:&lt;/b> This study was a prospective cohort study. A total of 194 female patients aged 18-60 years, American Society of Anesthesiologists (ASA) score I-II, who underwent laparoscopy at the Third Xiangya Hospital of Central South University, were included. The sedative effect was assessed every 2 min using the Ramsay score, and the patient's heart ra</pubmed_abstract><journal>Frontiers in pharmacology</journal><pagination>943200</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9301121</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>CYP2A6 and GABRA2 Gene Polymorphisms are Associated With Dexmedetomidine Drug Response.</pubmed_title><pmcid>PMC9301121</pmcid><pubmed_authors>Xia Y</pubmed_authors><pubmed_authors>Pei Q</pubmed_authors><pubmed_authors>Ouyang W</pubmed_authors><pubmed_authors>Chen M</pubmed_authors><pubmed_authors>Fang C</pubmed_authors><pubmed_authors>Zeng Y</pubmed_authors><pubmed_authors>Luo S</pubmed_authors></additional><is_claimable>false</is_claimable><name>CYP2A6 and GABRA2 Gene Polymorphisms are Associated With Dexmedetomidine Drug Response.</name><description>&lt;b>Background:&lt;/b> Dexmedetomidine is a commonly used clinical sedative; however, the drug response varies among individuals. Thus, the purpose of this study was to explore the association between dexmedetomidine response and gene polymorphisms related to drug-metabolizing enzymes and drug response (&lt;i>CYP2A6&lt;/i>, &lt;i>UGT2B10&lt;/i>, &lt;i>UGT1A4&lt;/i>, &lt;i>ADRA2A&lt;/i>, &lt;i>ADRA2B&lt;/i>, &lt;i>ADRA2C&lt;/i>, &lt;i>GABRA1&lt;/i>, &lt;i>GABRB2&lt;/i>, and &lt;i>GLRA1&lt;/i>). &lt;b>Methods:&lt;/b> This study was a prospective cohort study. A total of 194 female patients aged 18-60 years, American Society of Anesthesiologists (ASA) score I-II, who underwent laparoscopy at the Third Xiangya Hospital of Central South University, were included. The sedative effect was assessed every 2 min using the Ramsay score, and the patient's heart ra</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2026-05-09T14:24:28.134Z</modification><creation>2025-04-06T19:33:59.213Z</creation></dates><accession>S-EPMC9301121</accession><cross_references><pubmed>35873555</pubmed><doi>10.3389/fphar.2022.943200</doi></cross_references></HashMap>